Tangent: I'm invested in a small cap stock, Sophoris Bio, that's in a P2B study for prostrate cancer with a drug developed out of Johns Hopkins called PRX302 (T

Tangent: I'm invested in a small cap stock, Sophoris Bio, that's in a P2B study for prostrate cancer with a drug developed out of Johns Hopkins called PRX302 (Topsalysin). That and the article about blood tests shows there's a lot they're working on for noninvasive or minimally invasive procedures to help prevent cancer early on.